Danazol-induced hypercalcaemia in alphacalcidol-treated hypoparathyroidism

Hepburn NC, N C Hepburn, Abdul-Aziz LA, L A S Abdul-Aziz, L A Abdul-Aziz, R Whiteoak, Whiteoak R
Postgraduate medical journal · 1989 · vol. 65(769) , pp. 849–850 · doi:10.1136/pgmj.65.769.849 · PMID:2616424 · PMC2429221 · W1988120119
article OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

A patient with alphacalcidol-treated hypoparathyroidism developed hypercalcaemia while receiving danazol for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We report a case of idiopathic hypoparathyroidism, maintained on alphacalcidol who developed hypercalcaemia during treatment with danazol for endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Hydroxycholecalciferols Hypercalcemia Hypoparathyroidism Pregnadienes Adult Danazol Endometriosis Endometriosis Female Humans Hydroxycholecalciferols Hypercalcemia Hypoparathyroidism Pregnadienes

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

europepmc
last seen: 2026-07-09T06:07:56.200469+00:00
openalex
last seen: 2026-05-10T11:05:24.650074+00:00
pubmed
last seen: 2026-05-13T22:09:10.744835+00:00
License: CC0 · commercial use OK